搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Lactobacillus delbrueckii subsp. bulgaricus 50S ribosomal protein L5 (rplE) CSB-YP624782LAQ
CSB-EP624782LAQ
CSB-BP624782LAQ
CSB-MP624782LAQ
CSB-EP624782LAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus 50S ribosomal protein L3 (rplC) CSB-YP624783LAQ
CSB-EP624783LAQ
CSB-BP624783LAQ
CSB-MP624783LAQ
CSB-EP624783LAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus 33 kDa chaperonin (hslO) CSB-YP624784LAQ
CSB-EP624784LAQ
CSB-BP624784LAQ
CSB-MP624784LAQ
CSB-EP624784LAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus 50S ribosomal protein L31 type B (rpmE2) CSB-YP624785LAQ
CSB-EP624785LAQ
CSB-BP624785LAQ
CSB-MP624785LAQ
CSB-EP624785LAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus GMP reductase (guaC) CSB-YP624786LAQ
CSB-EP624786LAQ
CSB-BP624786LAQ
CSB-MP624786LAQ
CSB-EP624786LAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus 30S ribosomal protein S18 (rpsR) CSB-YP624787LAQ
CSB-EP624787LAQ
CSB-BP624787LAQ
CSB-MP624787LAQ
CSB-EP624787LAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP624788SAAR
CSB-EP624788SAAR
CSB-BP624788SAAR
CSB-MP624788SAAR
CSB-EP624788SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Protein translocase subunit SecA (secA), partial CSB-YP624789SAAR
CSB-EP624789SAAR
CSB-BP624789SAAR
CSB-MP624789SAAR
CSB-EP624789SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Ribonuclease PH (rph) CSB-YP624790SAAR
CSB-EP624790SAAR
CSB-BP624790SAAR
CSB-MP624790SAAR
CSB-EP624790SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. ATP-dependent protease subunit HslV (hslV) CSB-YP624791SAAR
CSB-EP624791SAAR
CSB-BP624791SAAR
CSB-MP624791SAAR
CSB-EP624791SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Ribonuclease HII (rnhB) CSB-YP624792SAAR
CSB-EP624792SAAR
CSB-BP624792SAAR
CSB-MP624792SAAR
CSB-EP624792SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. ATP synthase subunit c (atpE), partial CSB-YP624793SAAR1
CSB-EP624793SAAR1
CSB-BP624793SAAR1
CSB-MP624793SAAR1
CSB-EP624793SAAR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (ispH) CSB-YP624794SAAR
CSB-EP624794SAAR
CSB-BP624794SAAR
CSB-MP624794SAAR
CSB-EP624794SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. UvrABC system protein C (uvrC), partial CSB-YP624795SAAR
CSB-EP624795SAAR
CSB-BP624795SAAR
CSB-MP624795SAAR
CSB-EP624795SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. SsrA-binding protein (smpB) CSB-YP624796SAAR
CSB-EP624796SAAR
CSB-BP624796SAAR
CSB-MP624796SAAR
CSB-EP624796SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Formate--tetrahydrofolate ligase (fhs), partial CSB-YP624797SAAR
CSB-EP624797SAAR
CSB-BP624797SAAR
CSB-MP624797SAAR
CSB-EP624797SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Ketol-acid reductoisomerase (ilvC) CSB-YP624798SAAR
CSB-EP624798SAAR
CSB-BP624798SAAR
CSB-MP624798SAAR
CSB-EP624798SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. 30S ribosomal protein S4 (rpsD) CSB-YP624799SAAR
CSB-EP624799SAAR
CSB-BP624799SAAR
CSB-MP624799SAAR
CSB-EP624799SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. 7-cyano-7-deazaguanine synthase (queC) CSB-YP624800SAAR
CSB-EP624800SAAR
CSB-BP624800SAAR
CSB-MP624800SAAR
CSB-EP624800SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Elongation factor P (efp) CSB-YP624801SAAR
CSB-EP624801SAAR
CSB-BP624801SAAR
CSB-MP624801SAAR
CSB-EP624801SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>